1.
The Clinical Study of 12 Patients with Anaplastic Thyroid Cancer and Review of the Litereture
甲状腺未分化癌12例临床分析并文献复习
2.
Treatment and prognosis of anaplastic thyroid carcinoma
甲状腺未分化癌的治疗及预后因素的探讨
3.
Proteomic Analysis of Proliferation Inhibition of Docetaxel on Human Anaplastic Thyroid Cancer Cell Line (TA-K);
泰索帝作用于甲状腺未分化癌细胞系的蛋白质组学研究
4.
undifferentiated adenocarcinoma of thyroid
未分化性甲状腺腺癌
5.
undifferentiated adenoma of thyroid
未分化性甲状腺腺瘤
6.
Study on the Correlation between GLUT-1 and P63 in Poorly Differentiated Thyroid Carcinoma and Anaplastic Carcinoma Expression
甲状腺低分化癌和未分化癌中P63、GLUT-1的表达及其相关性研究
7.
Role of NF-κB in Chemotherapy Resistance Mechanism and Combination Therapy in Anaplastic Thyroid Cancer
核因子κB在未分化甲状腺癌化疗耐药机制和治疗中的作用
8.
Molecular Mechanism of Apoptosis Induced by PsL5F in Human Anaplastic Thyroid Carcinoma FRO Cells
PsL5F诱导人未分化甲状腺癌FRO细胞凋亡的机制研究
9.
Absorbed dose of salivary glands in patients with differentiated thyroid carcinoma receiving ~(131)I ablative therapy
分化型甲状腺癌患者首次“清甲”唾液腺吸收剂量
10.
The Prognostic Factors of 160 Patients with Differentiated Thyroid Carcinoma;
分化型甲状腺癌160例预后因素分析
11.
Analysis on the treatment of bilateral differentiated thyroid carcinoma:A report of 15 cases
15例双侧分化型甲状腺癌治疗分析
12.
Diagnosis and treatment of differentiated thyroid carcinoma:report of 76 cases
76例分化型甲状腺癌的诊断及治疗
13.
The Surgical Treatment for Differentiated Thyroid Carcinoma
分化型甲状腺癌手术治疗方法的探讨
14.
Research on the Expression of Protein Fascin in Differentiated Thyroid Carcinoma
Fascin蛋白在分化型甲状腺癌中的研究
15.
Influential Factors of Serum Thyroglobulin after Surgical Treatment of Differentiated Thyroid Carcinoma
分化型甲状腺癌患者术后血甲状腺球蛋白监测的影响因素分析
16.
Blood Lipids in Patients with Differentiated Thyroid Carcinoma on Suspension of Hormone Replacement Therapy
暂停甲状腺激素替代治疗对分化型甲状腺癌患者血脂的影响
17.
Value of Thyroid Stimulating Hormone Inhibition Therapy in Differentiated Thyroid Carcinoma
促甲状腺激素抑制疗法在分化型甲状腺癌治疗中的作用
18.
Combined Therapy of Molecular-Oriented NF-κB Inhibitor and Taxanes on Anaplastic Thyroid Cancer Cells
NF-κB抑制剂与紫杉烷联合靶向性化疗在未分化甲状腺癌治疗中的应用